See Recent Shionogi-Sponsored Congress Presentations
Congresses
As part of our commitment to addressing unmet medical needs, Shionogi continues to investigate approved products and pipeline compounds. Shionogi presents its research at major congress events globally.
The content contained herein is for your information only. No reproduction, alteration, or distribution of this information is permitted. Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.
Select a congress event or filter to view available congress presentations.
You Are Viewing Presentations
Cefiderocol treatment in patients with Gram-negative bacterial infections: European results of the global retrospective observational PROVE study
Cefiderocol treatment in patients with Gram-negative bacterial infections: European results of the global retrospective observational PROVE study
Clearance of infectious virus in COVID-19 patients treated with ensitrelvir across vaccination status, age, and risk subgroups: exploratory analyses from the SCORPIO-HR study
Clearance of infectious virus in COVID-19 patients treated with ensitrelvir across vaccination status, age, and risk subgroups: exploratory analyses from the SCORPIO-HR study
Clinical outcomes of cefiderocol for treatment of bloodstream infections caused by gram-negative bacteria: subgroup analysis of the PROVE study
Clinical outcomes of cefiderocol for treatment of bloodstream infections caused by gram-negative bacteria: subgroup analysis of the PROVE study
Comparative activity of cefiderocol on bloodstream infection isolates from US Hospital ICU patients
Comparative activity of cefiderocol on bloodstream infection isolates from US Hospital ICU patients
Comparison of conventional and iron-depleted agar plates for susceptibility testing of cefiderocol by disk diffusion
Comparison of conventional and iron-depleted agar plates for susceptibility testing of cefiderocol by disk diffusion
Correlation analysis of cefiderocol in vitro activity and in vivo efficacy against Acinetobacter baumannii strains with difficult-to-read MIC endpoints
Correlation analysis of cefiderocol in vitro activity and in vivo efficacy against Acinetobacter baumannii strains with difficult-to-read MIC endpoints
You Are Viewing Congress Locations
ASCP 2025
NACFC 2025
IDWeek 2025
AVG and IMRP 2025
ASM Microbe 2025
ESCMID 2025
CROI 2025
SCCM 2025
IDWeek 2024
NACFC 2024
IAS 2024
ESCMID 2024
